recombinant human papillomavirus bivalent vaccine (ree-KOM-bih-nunt HYOO-mun PA-pih-LOH-muh-VY-rus by-VAY-lent vak-SEEN)
A vaccine used to prevent cervical cancer caused by human papillomavirus (HPV) types 16 and 18. Recombinant human papillomavirus bivalent vaccine is approved for use in females aged 9 to 25 years. It is a type of bivalent vaccine (a vaccine that works against two different viruses or other microorganisms). Also called Cervarix.